Ask AI
ProCE Banner Activity

Therapy for Previously Treated Advanced HER2-Negative Gastric/GEJ Cancers

Slideset Download
Download these slides from a live webinar reviewing current and emerging therapies for previously treated advanced HER2-negative gastric/GEJ cancers.

Released: July 21, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant

Astellas Pharma US

Faculty Disclosure

Primary Author

Samuel J. Klempner, MD, FASCO

Director, Gastroesophageal Medical Oncology
Tobins Family Endowed Chair in Esophagogastric Cancer
Associate Professor, Harvard Medical School
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Samuel Klempner, MD: consultant/advisor/speaker: Astellas, AstraZeneca, Bristol-Myers Squibb, Daiichi-Sankyo, Exact Sciences, Lilly, Merck, Mersana, Sanofi-Aventis.